Detalles de la búsqueda
1.
The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome.
Int J Mol Sci
; 24(19)2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833904
2.
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.
Int J Mol Sci
; 24(3)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769087
3.
Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer.
Int J Mol Sci
; 24(6)2023 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36983028
4.
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
Semin Cancer Biol
; 72: 76-89, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881337
5.
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.
Int J Mol Sci
; 23(15)2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35897831
6.
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.
Breast Cancer Res Treat
; 181(2): 391-401, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32323103
7.
T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy.
Cancer Immunol Immunother
; 68(5): 705-707, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30955066
8.
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer.
Cancer Immunol Immunother
; 68(10): 1671-1680, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30905043
9.
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
Cancer Immunol Immunother
; 68(1): 57-70, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30276443
10.
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
Cancer Immunol Immunother
; 68(11): 1733-1745, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31598757
11.
2nd Symposium on Advances in Cancer Immunology and Immunotherapy, December 15-17, 2016, Athens, Greece.
Cancer Immunol Immunother
; 67(1): 153-159, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196790
12.
Immune profiling of melanoma tumors reflecting aggressiveness in a preclinical model.
Cancer Immunol Immunother
; 66(12): 1631-1642, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28871365
13.
Peripheral T cell responses to tumour antigens are associated with molecular, immunogenetic and cellular features of breast cancer patients.
Breast Cancer Res Treat
; 161(1): 51-62, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27787640
14.
Prostate cancer vaccines: the long road to clinical application.
Cancer Immunol Immunother
; 64(4): 401-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25690791
15.
A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit.
Cancer Immunol Immunother
; 64(9): 1123-36, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26026288
16.
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction.
Cancer Immunol Immunother
; 63(11): 1141-50, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25052849
17.
4th Symposium on Advances in Cancer Immunology and Immunotherapy, November 29-December 1, 2018, Athens, Greece.
Cancer Immunol Immunother
; 68(8): 1391-1400, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31309256
18.
AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial.
Cancer Immunol Immunother
; 62(10): 1599-608, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23934022
19.
NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
J Immunol
; 186(6): 3327-35, 2011 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21317394
20.
Immune Checkpoint Inhibitors in Cancer Therapy-How Can We Improve Clinical Benefits?
Cancers (Basel)
; 15(3)2023 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765836